COVID-19 vaccine progress check: Envoys from 100 countries to visit Serum Institue and Gennova Pharma in Pune

By: |
November 24, 2020 9:45 PM

Pune Divisional Commissioner Saurabh Rao said there was a possibility that Prime Minister Narendra Modi would also visit Pune, adding "if the visit happens, it would be at Serum Institute of India and Gennova Biophramaceuticals".

The Central Drug Standard Control Organisation has granted licence permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms, two of which are Serum Institute of India and Gennova Biopharmaceuticals.The Central Drug Standard Control Organisation has granted licence permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms, two of which are Serum Institute of India and Gennova Biopharmaceuticals.

Ambassadors and envoys from 100 countries will visit Serum Institute of India and Gennova Biopharmaceuticals Ltd here on December 4 amid the coronavirus outbreak and race for vaccines to combat the infection, a senior official said on Tuesday. Pune Divisional Commissioner Saurabh Rao said there was a possibility that Prime Minister Narendra Modi would also visit Pune, adding “if the visit happens, it would be at Serum Institute of India and Gennova Biophramaceuticals”.

The Central Drug Standard Control Organisation has granted licence permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms, two of which are Serum Institute of India and Gennova Biopharmaceuticals.

The PM’s visit, if it takes place, would be aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanisms, Rao said.

“We have not received any official communication from the PMO. However, we are making preparations for the probable visit (of the PM),” Rao told reporters.

He said the visit of the ambassadors was to take place on November 27, but it has now been rescheduled to December 4. Serum Institute of India, the worlds largest vaccine maker, has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 vaccine: China plays down its vaccine rivalry with India
2Covid-19 Vaccination drive: Over 19.5 lakh people vaccinated against coronavirus in India, says Health ministry
3Republic Day 2021: Why plant protein awareness is key to fulfilling India’s right to protein